Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Kdonkey,sorry I've posted before seeing your further post. i have never been clear exactly what fum are doing patent wise.i do recall the original announcement referred to an extension,but i could never really get to the botton of it.ive always assumed 3 to 4 years whatever they were doing.ive never been worried about the patent aspect in the sense of will they be successful,as although nothing is a given, fum have obtained a very large number of patents over the years and this was an aspect i felt they would approach with experience and confidence,albeit inevitably one which must take quite some time. i entirely agree with your point by the way,about it being very important to add value.let us hope for further new soon.
Kdonkey,the note you refer to does,i think,relate to the national applications stage of the PCT process,which happens after the initial(international stage )has been completed.so fum had completed the first phase by q2 2022. that seems a reasonable time scale as the application is not published until 18 months after filing and there are searches etc to be carried out after that before you can proceed to the national stage.the national stage length depends on how many countries/areas are involved and their individual requirements,but i would hope between 1 to two years,so hopefully we will get some news by end of this year. im no expert and just my layman's appraisal https://www.wipo.int/pct/en/faqs/faqs.html
after doing a scan, you were right Italian it does tak 3-4 years to get a patent. But, we already have a patent on Dermasys. From what I can figure out, FUM maybe amending the patent under Section 75. I did look up Section 27, which is also mentioned on the governments website regarding amending patents, but this doesn't seem correct (unless someone else want to take a look)
Biggest bummer is it doesn't say how long it takes to amend the original patent.
FUM have done it before, maybe some of the really long term holders can remember how long it took before
The.I, below are patent notes from the latest results. If it is based on your 3-4 years then it won't be annouced until 2025-26. I thought patents took about 18 months, but I could be wrong. Might need to do some more research
'In Q2 2022, as part of its overall IP protection strategy, Futura filed national patent applications considered necessary to protect the commercial interests of MED3000 in line with normal PCT filing procedures in all key ED markets. If successful, this will provide patent protection until 2040.'
Ive got a semi just from todays price increase
fum applied for the patent extension in dec 2019.patent applications take a long time.i have personally been working on an assumption of between 3 and 4 years.so im hoping for news by the end of this year.just my personal guess of course.
you cannot forget that ***
"I should think next country might be Belgium"
What's your thinking on this BruceJamieson as Belgium is already selling Eroxon ?
Asw I just checked the stores near me are showing as in stock from Penge to Sevenoaks
I looked at the Boots site for Eroxon this evening, the reviews were really good! I see that the stores near me as Leatherhead, Bromley and Sutton are all sold out! Would this be because the stores didn’t stock much inventory and forecasts were too low for sales that are way more than expected?? Or significant unplanned demand in the London commuter belt? I think it is a good sign, just want to make sure Coopers don’t launch in too many countries too soon and run out of manufacturing capacity for such a product as this where repeat business is key to continued longer term growth.
I should think next country might be Belgium
kdonkey - good point about the patent extension - that would in itself prove to be a very likely large increase in the SP.
With good sales data from Europe, FDA approval and patent extension I reckon someone would pay £1B for FUM or around £3 per share. The longer it’s left and the higher the revenue generated the greater the buyout price.
There is clearly a ramp up program bringing sales and revenue on stream by country. Belgium, UK, each time giving the stock a rise.
Any side bets on the next country to launch?
I'd go with France ???? within the next month. Should be a very willing market to deliver another rise or two.
Yes, totally K1000.
All M&G,s are subject to their due diligence. I am guessing there are some big boys in their labs beavering away looking for ways around the current patient.
Waiting to hear from the company brokers, surly they have a view with all this new information. They have been reiterating their position on no real information in the past.
81lucky, I also think it depends on the patent. The current one expires in 2029 and I don't think any company will pay a premium if it's only 6 years. But if they get the extension, which will expire in 2040 then I think we'll see a bidder paying a decent price. imo
Dactions: M&A scenario is the only way I have seen this go. And as you say, we should do well, however, an agreed buyout could be detrimental as the board could agree to what they would be looking for, which may not be in unison with the lth pi,s. We could end up with a Ronald Wayne moment.
My guess is that those predictor Pharma s will be looking at the US market for indication of the potential, UK and EU being a good indicative precursor. Also, it will depend upon the type of M&A, Horizontal or conglomerate.
Banzai eBay........ I think you will find it's not official so no RNS needed, my guess is somebody has purchased from Boots £24.99 split the box of 4 and selling 1 tube for £14.99.Not sure why anybody would pay £14.99 for 1 tube but there you go!!!!
just to get a sense of the sales, I've been clicking on and off the Boots site -- the last "last sale" time lapse is rarely more than 15 seconds.. .... how many 15 seconds in a day ... a week... a month... a year....? LOTS TO COME !
The SP here is pretty muted considering the SP increases on speculation over the years has been far higher! Now we have a product on the market surely SP should be rising rapidly? Nobody’s interested in the physical world anymore, they are more interested in hype & speculation! Shares are very strange things especially on AIM, I’m finding this out the herd way!
I would have liked to see the sp higher at this stage - at least around the 75p level based on the strong indications after the Belgium launch. Remember it's been a whole 2 years since we had the approx 85p spike following the announcement of the CE marking. It then fell back relatively quickly to around 50p and stabilised there for a while - now we're at last back to those levels. Unfortunately, Barder's always been playing a long game - whether that's by accident or design (I think accident) and he'll believe he's been right all the way along. Remember he has a very large shareholding, never mind his options.
In my opinion, we will definitely see another spike once the FDA approves it as an OTC product but the fact that the sp is where it is now means the sp will only respond in future to actual details of sales - something I don't think we'll get for a good while.
I first purchased FUM over 10 years ago but around 60p - fortunately I bought in again when they did the 7p placing which Lombard Odier supported big time - but I think we still have to be patient as to sp growth if FUM stays independent. The quickest way we'll do really well with FUM is, in my opinion, a buyout - something I'm hoping for.
There is a lot relying on the FDA approval, and I'd certainly think we would see a huge peak in the share price.
Ideally if there was a sales update / RNS at a similar time.
Everything is lined up here, and actually happening now - eg it's got to market. Bring on FDA and then get it to market in USA. Think there's a few more ups and downs along the way, but the sky is the limit at the moment.
Huge … an interesting play … back over £1 anyone think ?
Wow I'd forgotten that name. That guy definitely had some issues with FUM. I bet he'll give Eroxon a whirl though!
Great commentary from Petroc over on ADVFN, it made me laugh anyway. Poor old Liam Booth, he is going to go into meltdown when the share price passes through a pound.